Nuvectis Pharma NVCT
NASDAQ NVCT
$20.72 -0.40 (-1.89%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nuvectis Pharma (NVCT) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Nuvectis Pharma's Liabilities and Shareholders Equity was $22.38 million in Q2 2026, down 17.1% from $27.01 million a year earlier and down 11.9% from the prior quarter.

Analysis

Nuvectis Pharma (NVCT) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Nuvectis Pharma came in at $31.71 million, up 70.4% from FY2024.

  • Liabilities and Shareholders Equity shows a four-year compound annual growth rate of 47.7% (FY2021 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $18.61 million in FY2024 (-3.0%), $19.19 million in FY2023 (-6.0%), $20.41 million in FY2022 (+206.5%) and $6.66 million in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q4 2024.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in four of the last eight quarters, with growth averaging 27.3%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q4 2022 (growth of 206.5%); the worst was Q2 2024 (a decline of 26.6%).
  • Per Business Quant data, NVCT's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $25.4 million (Q1 2026), $31.71 million (Q4 2025) and $35.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Nuvectis Pharma 563.79 Mn 563.79 Mn - 22.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.38 Mn
Mar 31, 2026 25.40 Mn
Dec 31, 2025 31.71 Mn
Sep 30, 2025 35.59 Mn
Jun 30, 2025 27.01 Mn
Mar 31, 2025 30.15 Mn
Dec 31, 2024 18.61 Mn
Sep 30, 2024 17.31 Mn
Jun 30, 2024 18.30 Mn
Mar 31, 2024 19.71 Mn
Dec 31, 2023 19.19 Mn
Sep 30, 2023 22.26 Mn
Jun 30, 2023 24.94 Mn
Mar 31, 2023 16.21 Mn
Dec 31, 2022 20.41 Mn
Sep 30, 2022 24.87 Mn
Jun 30, 2022 14.24 Mn
Mar 31, 2022 17.62 Mn
Dec 31, 2021 6.66 Mn
API Access

Nuvectis Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NVCT&period=max&api_key=YOUR_API_KEY